Enovis Corp Ownership
| ENOV Stock | USD 26.30 0.01 0.04% |
Shares in Circulation | First Issued 2006-03-31 | Previous Quarter 58.4 M | Current Value 56.8 M | Avarage Shares Outstanding 34.8 M | Quarterly Volatility 17 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enovis Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. Enovis Stock Ownership Analysis
About 98.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.57. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enovis Corp has Price/Earnings To Growth (PEG) ratio of 1.9. The entity recorded a loss per share of 14.64. The firm had not issued any dividends in recent years. Enovis Corp had 581:1000 split on the 5th of April 2022. Enovis Corporation operates as a medical technology company worldwide. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies and directly under the DJO brand. Enovis Corp operates under Specialty Industrial Machinery classification in the United States and is traded on New York Stock Exchange. It employs 16200 people. To learn more about Enovis Corp call Matthew Trerotola at 302 252 9160 or check out https://www.enovis.com.Besides selling stocks to institutional investors, Enovis Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Enovis Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Enovis Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Enovis Corp Quarterly Liabilities And Stockholders Equity |
|
Enovis Corp Insider Trades History
Only 1.54% of Enovis Corp are currently held by insiders. Unlike Enovis Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Enovis Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Enovis Corp's insider trades
Enovis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Enovis Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enovis Corp backward and forwards among themselves. Enovis Corp's institutional investor refers to the entity that pools money to purchase Enovis Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of America Corp | 2025-03-31 | 1.2 M | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 1.1 M | Boston Partners Global Investors, Inc | 2025-03-31 | 971 K | Geode Capital Management, Llc | 2025-03-31 | 933.9 K | Ubs Group Ag | 2025-03-31 | 848.3 K | Exoduspoint Capital Management, Lp | 2025-03-31 | 845.8 K | Royal Bank Of Canada | 2025-03-31 | 799.3 K | Paradigm Capital Management, Inc. | 2025-03-31 | 786.4 K | Charles Schwab Investment Management Inc | 2025-03-31 | 712.8 K | Blackrock Inc | 2025-03-31 | 7.2 M | T. Rowe Price Investment Management,inc. | 2025-03-31 | 6.2 M |
Enovis Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Enovis Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Enovis Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Enovis Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Enovis Corp Outstanding Bonds
Enovis Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Enovis Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Enovis bonds can be classified according to their maturity, which is the date when Enovis Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Enovis Corp Corporate Filings
| 17th of July 2025 Other Reports | ViewVerify | |
F4 | 1st of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 26th of June 2025 Other Reports | ViewVerify | |
| 30th of May 2025 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Enovis Stock Analysis
When running Enovis Corp's price analysis, check to measure Enovis Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enovis Corp is operating at the current time. Most of Enovis Corp's value examination focuses on studying past and present price action to predict the probability of Enovis Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enovis Corp's price. Additionally, you may evaluate how the addition of Enovis Corp to your portfolios can decrease your overall portfolio volatility.